CENTRIENT PHARMACEUTICALS INDIA RIT LTD

CENTRIENT PHARMACEUTICALS INDIA RIT LTD is a Factory (Manufacturer).

Company Introduction:

Centrient Pharmaceuticals India RIT Ltd is the Indian subsidiary of Centrient Pharmaceuticals, a global leader in the sustainable production of essential medicines. The company operates primarily as a manufacturing entity, with a significant production facility in India dedicated to the development and production of high-quality pharmaceutical ingredients. Centrient Pharmaceuticals is renowned for its innovative enzymatic production processes, which enable the creation of sustainable antibiotics, next-generation statins, and anti-fungals with a reduced environmental impact. Centrient Pharmaceuticals India RIT Ltd plays a vital role in the global supply chain of active pharmaceutical ingredients (APIs), ensuring the availability of crucial medicines. Its operations encompass advanced manufacturing, stringent quality control, and a commitment to sustainable practices, serving both the Indian market and contributing to global pharmaceutical needs.

Centrient Pharmaceuticals India Private Limited (assuming this is the intended company, as 'RIT LTD' is not a commonly recognized suffix for Centrient Pharmaceuticals in India) manufactures and sells a diverse portfolio of products. These include a broad range of Active Pharmaceutical Ingredients (APIs) such as Amoxicillin, Ampicillin, Cefaclor, Cefadroxil, Cefalexin, Cefixime, Cefpodoxime, Cefprozil, Ceftibuten, Ceftriaxone, Cefuroxime Axetil, Clarithromycin, Erythromycin, Pravastatin Sodium, Simvastatin, Rosuvastatin Calcium, Atorvastatin Calcium, Caspofungin, Micafungin, Anidulafungin, Baclofen, Clonidine HCl, Dexmedetomidine HCl, Fluconazole, Gabapentin, Irbesartan, Levetiracetam, Losartan Potassium, Montelukast Sodium, Olanzapine, Ondansetron HCl, Pantoprazole Sodium, Pioglitazone HCl, Pregabalin, Quetiapine Fumarate, Ramipril, Valsartan, and Venlafaxine HCl.

The company also produces various Advanced Intermediates primarily for the synthesis of antibiotics and statins.

Furthermore, Centrient Pharmaceuticals India Private Limited offers Finished Dosage Forms (FDFs), including tablets, capsules, oral suspensions, and injectables, focusing on therapeutic areas such as anti-infectives and cardiovascular diseases.